Cargando…
Estimation of Direct Medical Costs Related to Chronic Hepatitis C: A Rationale for Early Antiviral Therapy
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Editorial Office of Gut and Liver
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669589/ https://www.ncbi.nlm.nih.gov/pubmed/29081211 http://dx.doi.org/10.5009/gnl17408 |
| _version_ | 1783275867131084800 |
|---|---|
| author | Kim, Do Young |
| author_facet | Kim, Do Young |
| author_sort | Kim, Do Young |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5669589 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Editorial Office of Gut and Liver |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-56695892017-11-07 Estimation of Direct Medical Costs Related to Chronic Hepatitis C: A Rationale for Early Antiviral Therapy Kim, Do Young Gut Liver Editorial Editorial Office of Gut and Liver 2017-11 2017-11-15 /pmc/articles/PMC5669589/ /pubmed/29081211 http://dx.doi.org/10.5009/gnl17408 Text en Copyright © 2017 by The Korean Society of Gastroenterology, the Korean Society of Gastrointestinal Endoscopy, the Korean Society of Neurogastroenterology and Motility, Korean College of Helicobacter and Upper Gastrointestinal Research, Korean Association the Study of Intestinal Diseases, the Korean Association for the Study of the Liver, Korean Pancreatobiliary Association, and Korean Society of Gastrointestinal Cancer. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Kim, Do Young Estimation of Direct Medical Costs Related to Chronic Hepatitis C: A Rationale for Early Antiviral Therapy |
| title | Estimation of Direct Medical Costs Related to Chronic Hepatitis C: A Rationale for Early Antiviral Therapy |
| title_full | Estimation of Direct Medical Costs Related to Chronic Hepatitis C: A Rationale for Early Antiviral Therapy |
| title_fullStr | Estimation of Direct Medical Costs Related to Chronic Hepatitis C: A Rationale for Early Antiviral Therapy |
| title_full_unstemmed | Estimation of Direct Medical Costs Related to Chronic Hepatitis C: A Rationale for Early Antiviral Therapy |
| title_short | Estimation of Direct Medical Costs Related to Chronic Hepatitis C: A Rationale for Early Antiviral Therapy |
| title_sort | estimation of direct medical costs related to chronic hepatitis c: a rationale for early antiviral therapy |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669589/ https://www.ncbi.nlm.nih.gov/pubmed/29081211 http://dx.doi.org/10.5009/gnl17408 |
| work_keys_str_mv | AT kimdoyoung estimationofdirectmedicalcostsrelatedtochronichepatitiscarationaleforearlyantiviraltherapy |